Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.

Author(s): Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, Hernán MA, Lipsitch M, Hernández-Díaz S, Reis BY, Balicer RDJournal: Nat MedPMID: 34493859 September 2021
To evaluate the effectiveness of the BNT162b2 messenger RNA vaccine in pregnant women, we conducted an observational cohort study of…

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.

Author(s): Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, Hernán MA, Lipsitch M, Kohane I, Netzer D, Reis BY, Balicer RDJournal: N Engl J MedPMID: 34432976 August 2021
Preapproval trials showed that messenger RNA (mRNA)-based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety…

Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine in Pregnancy

Author(s): Balicer R, Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane I, Hernan M, Lipsitch M, Hernández-Díaz S, Reis BJournal: Res Sq July 2021
As mass vaccination campaigns against COVID-19 accelerate worldwide, there remains only limited evidence regarding vaccine effectiveness (VE) among pregnant women.…